Search research articles
Contact Us
Filters
Showing results (1-10 of 447) with videos related to
Page
of 45
Sort By:
Journal of the American College of Cardiology
|
October 11, 2014
Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized heart failure
Stephen J Greene, Mihai Gheorghiade
JAMA
|
July 25, 2014
Influence of chronic kidney disease on warfarin therapy for atrial fibrillation
Muthiah Vaduganathan, Stephen J Greene
Circulation
|
November 27, 2023
Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral Diuretics
Stephen J Greene, Javed Butler
Journal of Cardiac Failure
|
March 19, 2026
The Role of Vericiguat for Treatment of Heart Failure with Reduced Ejection Fraction
Stephen J Greene, Javed Butler
CJEM
|
June 21, 2017
Bulletproof heart: Gunshot wound to the ventricular septum without pericardial effusion or hemodynamic collapse
Lora Alkhawam, Stephen J Greene
European Journal of Heart Failure
|
August 21, 2015
Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?
Stephen J Greene, Mihai Gheorghiade
Journal of the American College of Cardiology
|
October 8, 2021
Investigator-Reported Versus Adjudicated Clinical Events: 2 Versions of the Truth?
Stephen J Greene, Javed Butler
Circulation
|
January 8, 2019
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus
Stephen J Greene, Javed Butler
Journal of the American College of Cardiology
|
March 14, 2015
Reply: considerations for drug development for heart failure
Stephen J Greene, Mihai Gheorghiade
JACC. Heart Failure
|
July 11, 2021
Practical and Evidence-Based Approaches to In-Hospital Decongestion for Heart Failure: Are We There Yet?
Stephen J Greene, Muhammad Shahzeb Khan
Page
of 45
Search research articles
Search
Showing results (1-10 of 447) with videos related to
Sort By:
Page
of 45
Journal of the American College of Cardiology
|
October 11, 2014
Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized heart failure
Stephen J Greene, Mihai Gheorghiade
JAMA
|
July 25, 2014
Influence of chronic kidney disease on warfarin therapy for atrial fibrillation
Muthiah Vaduganathan, Stephen J Greene
Circulation
|
November 27, 2023
Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral Diuretics
Stephen J Greene, Javed Butler
Journal of Cardiac Failure
|
March 19, 2026
The Role of Vericiguat for Treatment of Heart Failure with Reduced Ejection Fraction
Stephen J Greene, Javed Butler
CJEM
|
June 21, 2017
Bulletproof heart: Gunshot wound to the ventricular septum without pericardial effusion or hemodynamic collapse
Lora Alkhawam, Stephen J Greene
European Journal of Heart Failure
|
August 21, 2015
Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?
Stephen J Greene, Mihai Gheorghiade
Journal of the American College of Cardiology
|
October 8, 2021
Investigator-Reported Versus Adjudicated Clinical Events: 2 Versions of the Truth?
Stephen J Greene, Javed Butler
Circulation
|
January 8, 2019
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus
Stephen J Greene, Javed Butler
Journal of the American College of Cardiology
|
March 14, 2015
Reply: considerations for drug development for heart failure
Stephen J Greene, Mihai Gheorghiade
JACC. Heart Failure
|
July 11, 2021
Practical and Evidence-Based Approaches to In-Hospital Decongestion for Heart Failure: Are We There Yet?
Stephen J Greene, Muhammad Shahzeb Khan
Page
of 45